Broker Newswire
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Online Trading
    • Cryptocurrencies
    • Stocks
  • Markets
    • Earnings
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Saving money
    • Retirement
  • Economy
  • Tech
    • Enterprise
    • Internet
SUBSCRIBE
No Result
View All Result
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Online Trading
    • Cryptocurrencies
    • Stocks
  • Markets
    • Earnings
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Saving money
    • Retirement
  • Economy
  • Tech
    • Enterprise
    • Internet
No Result
View All Result
Broker Newswire
No Result
View All Result
Home Investing Acquisitions

Evotec Set To Acquire Aptuit For $300 Million

by Jay Helton
July 30, 2017
2 min read
0
evotec ag
Share on FacebookShare on Twitter

On July the 30th, Evotec AG and Aptuit announced they had entered in a definitive agreement, which will see Evotec acquire Aptuit for $300 million. Evotec specializes in drug discovery and development. The company operates worldwide and provides stand-alone and integrated drug discovery solutions. APTUIT offers a comprehensive set of integrated early discovery to mid-phase drug development services. APTUIT offers development and fully integrated drug discovery services from their facilities in the United Kingdom, Switzerland and Italy.

Through the agreement, Evotec will strengthen its position as one of the leading global players in the external innovation market. Simultaneously, the acquisition will provide Evotec with considerable opportunities to accelerate its long-term strategy to be the industry partner of choice for external innovation. To day, Aptuit has roughly 750 employees with most being scientists.

These experts work in discovery, development and manufacturing facilities in Verona, Italy, Oxford, United Kingdom, and Basel, Switzerland. In 2016, Aptuit completed more than 1,000 projects for more than 400 customers. The firm has a strong network in small to medium-sized Biopharma and a high level of repeat business.

RELATED STORIES

Volkswagen must pay damages

Volkswagen must pay damages to buyers of manipulated diesel cars

May 25, 2020
Future Cloud Banking and Fintech

Future Cloud Predictions for Banking and Fintech Sector

April 23, 2020

The acquisition will give Evotec access to additional capacity and proven expertise. Evotec sincerely believes that Aptuit’s scientists and managers will prove to be valuable assets for their company. With a strong cultural fit between the two firms, Evotec believes the integration will be smooth and seamless. Before the acquisition, Aptuit had strong, growing financials. Reported revenues for 2016 were approximately 88 m EUR. Expected 2017 revenues topped out at 110 m EUR.

Evotec will pay $300 m or 256 m EUR to acquire Aptuit from Welsh, Carson, Anderson & Stowe. Evotec expects to provide a full guidance update as soon as the transaction closes. That is expected to happen during the 3rd quarter of 2017. More details can be found here. Evotec will be holding a conference call to discuss the details of the acquisition. The conference call be held on Monday, July the 31st at 2 PM CEST or 8 AM EDT.

Tags: evotecevotec agEVT
Create your Web Presence with Namecheap

Recent Posts

  • Bitcoin and crypto spending is allowed by PayPal Now
  • The event in the live stream: Apple releases 5G-capable iPhone – Business
  • Volkswagen thriller: An unpopular supplier, audio recordings and a dead man
  • Tencent and WeChat also affected: Why Trump’s TikTok ban could harm Silicon Valley
  • Hacker attack on Twitter: “Group of young people” is supposed to be behind the attack on the social media platform

Category

  • Acquisitions
  • Broker Related
  • Earnings Reports
  • Economy
  • Enterprise
  • General
  • Internet
  • Investing
  • IPO News
  • Latest News
  • Layoffs
  • Markets
  • Online Trading
  • Opinion
  • OTC Markets
  • Penny Stocks
  • Personal Finance
  • Retirement
  • Saving money
  • Stocks
  • Technology

About Us

Broker Newswire (BN) is an exciting new online publication, which targets finances, brokers, mortgage and markets. BN, which is the nation’s leading provider of real estate, finance and market news and analysis.

  • About
  • Advertise
  • Privacy & Policy
  • Feedback

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Cryptocurrencies
    • Online Trading
    • Stocks
  • Markets
    • Earnings Reports
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Retirement
    • Saving money
  • Economy
  • Tech
    • Enterprise
    • Internet
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.